What is the address of KADALE MEDICAL?

The registered office of KADALE MEDICAL is located at Avenue du Cheret 23, 4053 Chaudfontaine.

Is KADALE MEDICAL still active?

Yes. According to the CBE (16 September 2026) KADALE MEDICAL is active, legal situation “Normale toestand”, started on 20 October 2020.

Is KADALE MEDICAL registered on Peppol?

Yes, KADALE MEDICAL is registered on the Peppol network with ID 0208:0756773016.

What is the enterprise number of KADALE MEDICAL?

The enterprise number of KADALE MEDICAL is BE0756773016.

When was KADALE MEDICAL founded?

KADALE MEDICAL was founded on 20 October 2020.

Who are the directors of KADALE MEDICAL?

According to the 2024 annual accounts, the directors of KADALE MEDICAL are: JEAN-VINCENT BAVI.

Is KADALE MEDICAL a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 20 October 2020; 4 annual accounts filed, latest fiscal year 2024; 1 directors known from the annual account.

How much profit did KADALE MEDICAL make in 2024?

KADALE MEDICAL posted a profit after taxes of € 125,956 in financial year 2024.

What is the revenue of KADALE MEDICAL?

As a small company, KADALE MEDICAL is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 232,003.

KADALE MEDICAL (Private Limited) - Chaudfontaine

Dossier KADALE MEDICAL, printed on 16 September 2026 from databakkes.be/en/0756773016/kadale-medical. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2024

KADALE MEDICAL from Chaudfontaine, company number BE0756773016, closed financial year 2024 with a result of € 125,956 after tax. For that financial year KADALE MEDICAL recorded a gross margin of € 232,003 and equity of € 508,216. Compared with financial year 2023, the result moved from € 139,835 to € 125,956. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 23, 2025.

What it is worth Growing

€ 508,216

▲ 18% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 125,956

▼ 10% vs 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 243,374

▲ 2% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 50,000 paid out

40 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2024

Wage cost

€ 1,520

▼ 14% vs 2023

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 50,952

▼ 6% vs 2023

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt ≈ 7 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 167,509

▲ 4% vs 2023

€ 25,177 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.

Owed to suppliers

€ 48,120

▲ € 41,036 vs 2023

Supplier invoices still open on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 258,144 Gross margin 2021: € 258,144 First fiscal year in the series	€ 173,045 Gross margin 2022: € 173,045 ▼ 33% vs 2021 (€ 258,144) Unfavourable step	€ 221,674 Gross margin 2023: € 221,674 ▲ 28% vs 2022 (€ 173,045) Favourable step	€ 232,003 Gross margin 2024: € 232,003 ▲ 5% vs 2023 (€ 221,674) Favourable step	▲ 5%
Profit after taxes	€ 179,046 Profit after taxes 2021: € 179,046 First fiscal year in the series	€ 111,379 Profit after taxes 2022: € 111,379 ▼ 38% vs 2021 (€ 179,046) Unfavourable step	€ 139,835 Profit after taxes 2023: € 139,835 ▲ 26% vs 2022 (€ 111,379) Favourable step	€ 125,956 Profit after taxes 2024: € 125,956 ▼ 10% vs 2023 (€ 139,835) Unfavourable step	▼ 10%
Equity	€ 181,046 Equity 2021: € 181,046 First fiscal year in the series	€ 292,425 Equity 2022: € 292,425 ▲ 62% vs 2021 (€ 181,046) Favourable step	€ 432,260 Equity 2023: € 432,260 ▲ 48% vs 2022 (€ 292,425) Favourable step	€ 508,216 Equity 2024: € 508,216 ▲ 18% vs 2023 (€ 432,260) Favourable step	▲ 18%
Total debts	€ 141,707 Total debts 2021: € 141,707 First fiscal year in the series	€ 271,021 Total debts 2022: € 271,021 ▲ 91% vs 2021 (€ 141,707) Unfavourable step	€ 178,706 Total debts 2023: € 178,706 ▼ 34% vs 2022 (€ 271,021) Favourable step	€ 273,423 Total debts 2024: € 273,423 ▲ 53% vs 2023 (€ 178,706) Unfavourable step	▲ 53%
Cash	€ 130,934 Cash 2021: € 130,934 First fiscal year in the series	€ 218,912 Cash 2022: € 218,912 ▲ 67% vs 2021 (€ 130,934) Favourable step	€ 239,675 Cash 2023: € 239,675 ▲ 9% vs 2022 (€ 218,912) Favourable step	€ 243,374 Cash 2024: € 243,374 ▲ 2% vs 2023 (€ 239,675) Favourable step	▲ 2%
Land & buildings	-	€ 135,434 Land & buildings 2022: € 135,434 First fiscal year in the series	€ 131,313 Land & buildings 2023: € 131,313 ▼ 3% vs 2022 (€ 135,434) Unchanged	€ 212,175 Land & buildings 2024: € 212,175 ▲ 62% vs 2023 (€ 131,313) Unchanged	▲ 62%
Retained profit	€ 179,046 Retained profit 2021: € 179,046 First fiscal year in the series	€ 290,425 Retained profit 2022: € 290,425 ▲ 62% vs 2021 (€ 179,046) Favourable step	€ 430,260 Retained profit 2023: € 430,260 ▲ 48% vs 2022 (€ 290,425) Favourable step	€ 506,216 Retained profit 2024: € 506,216 ▲ 18% vs 2023 (€ 430,260) Favourable step	▲ 18%
Dividend	€ 0 Dividend 2021: € 0 First fiscal year in the series	€ 0 Dividend 2022: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 50,000 Dividend 2024: € 50,000 Unchanged (€ 0) Unchanged
Bank debt	€ 77,711 Bank debt 2021: € 77,711 First fiscal year in the series	€ 179,723 Bank debt 2022: € 179,723 ▲ 131% vs 2021 (€ 77,711) Unfavourable step	€ 161,381 Bank debt 2023: € 161,381 ▼ 10% vs 2022 (€ 179,723) Favourable step	€ 167,509 Bank debt 2024: € 167,509 ▲ 4% vs 2023 (€ 161,381) Unfavourable step	▲ 4%
Balance sheet total	€ 322,754 Balance sheet total 2021: € 322,754 First fiscal year in the series	€ 563,446 Balance sheet total 2022: € 563,446 ▲ 75% vs 2021 (€ 322,754) Unchanged	€ 610,966 Balance sheet total 2023: € 610,966 ▲ 8% vs 2022 (€ 563,446) Unchanged	€ 781,639 Balance sheet total 2024: € 781,639 ▲ 28% vs 2023 (€ 610,966) Unchanged	▲ 28%

Key figures of KADALE MEDICAL, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to KADALE MEDICAL?

What happened at KADALE MEDICAL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 23, 2025 New annual accounts for financial year 2024: profit of € 125,956 (▼ 10% vs 2023). filed late Source: NBB ↗
Oct 20, 2020 New establishment in Chaudfontaine. KBO
Oct 20, 2020 Start of the company according to the CBE. KBO

In short

From € 179,046 profit in 2021 to € 125,956 profit in 2024.

Paid € 189,299 in corporate taxes since 2021.

Best year ever: 2021, with € 179,046 profit.

Paid out € 50,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at KADALE MEDICAL? We notify you, reason included.

Follow KADALE MEDICAL

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

JEAN-VINCENT BAVI

KADALE MEDICAL

Behind KADALE MEDICAL is JEAN-VINCENT BAVI.

See the full network in the app

Directors

According to the 2024 annual accounts

JEAN-VINCENT BAVI

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Avenue du Cheret 23

4053 Chaudfontaine

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0756.773.016
VAT number: BE 0756.773.016
Registered office: Avenue du Cheret 23, 4053 Chaudfontaine
Names & denominations: KADALE MEDICAL
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 20 October 2020
Peppol: Active · Active since 20 Mar 2026

View on CBE Public ↗ Annual accounts (NBB) ↗